The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss.

The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone

Combined Hydroxyapatite Scaffold and Stem Cell from Human Exfoliated Deciduous Teeth Modulating Alveolar Bone Regeneration via Regulating Receptor Activator of Nuclear Factor-Κb and Osteoprotegerin System

Background: Tissue engineering using Stem cell from Human Exfoliated Deciduous Teeth (SHED) and a natural biomaterials biomaterial scaffold has become a promising therapy for the alveolar bone defect. The aim of this study was to analyze the Osteoprotegerin (OPG) and Receptor Activator of NF-Κb ligand (RANKL) expression after the application of Hydroxyapatite scaffold and SHED.Methods: A labora...

Elevated serum osteoprotegerin levels in women: friend or foe?

INTRODUCTION osteoprotegerin has emerged as a new candidate for the treatment of osteoporosis. However, high levels of osteoprotegerin have been linked to vascular calcification, an independent and well-defined risk factor for cardiovascular disease (CVD) and mortality. Thus, the action of osteoprotegerin in these situations has been questioned. OBJECTIVE to evaluate the effect of osteoproteg...

The Effect of an Incremental Training Rehabilitation Period on the Serum Levels of Pentraxin-3 and Osteoprotegerin in Rats With Myocardial Infarction

Aims Activation of inflammatory processes is necessary immediately after myocardial infarction (MI), but if it continues excessively, it can facilitate the occurrence of MI. Considering the positive effects of exercise on inflammatory pathways and their reduction, it seems to play a crucial role in improving the condition of MI patients. Accordingly, the present study investigated the effect of...

The role of osteoprotegerin in arthritis

Bone erosion is a hallmark of rheumatoid arthritis. Recent evidence from experimental arthritis suggests that osteoclasts are essential for the formation of local bone erosions. Two essential regulators of osteoclastogenesis have recently been described: the receptor-activator of nuclear factor kappa B ligand, which promotes osteoclast maturation, and osteoprotegerin (OPG), which blocks osteocl...